2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Motor Activity
249
Breast Neoplasms
136
Neoplasms
108
Prostatic Neoplasms
35
Fatigue
35
Obesity
25
Lung Neoplasms
24
Colorectal Neoplasms
24
Polycystic Ovary Syndrome
17
Colonic Neoplasms
16
Ovarian Neoplasms
13
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Pancreatic Neoplasms
11
Lymphoma
11
Lymphedema
11
Hematologic Neoplasms
11
Carcinoma, Non-Small-Cell Lung
11
Weight Loss
10
Rectal Neoplasms
10
Multiple Myeloma
10
Head and Neck Neoplasms
10
Leukemia
9
Cardiotoxicity
9
Insulin Resistance
8
Brain Neoplasms
8
Stomach Neoplasms
7
Peripheral Nervous System Diseases
7
Overweight
6
Esophageal Neoplasms
6
Cognitive Dysfunction
6
Interventions
Gemcitabine
112
Cisplatin
76
Oxaliplatin
45
pembrolizumab
35
Fluorouracil
32
Capecitabine
31
lenvatinib
26
durvalumab
26
Leucovorin
26
Magnetic Resonance Spectroscopy
14
Irinotecan
13
Drug Therapy
13
Nivolumab
12
Biopsy
12
Albumin-Bound Paclitaxel
12
Specimen Handling
11
Radiofrequency Ablation
11
130-nm albumin-bound paclitaxel
11
tislelizumab
10
pemigatinib
10
apatinib
10
Taxes
10
Radiotherapy
10
Floxuridine
10
Folfox protocol
9
Bevacizumab
9
S 1 (combination)
8
Photochemotherapy
8
Liver Transplantation
8
Cholangiopancreatography, Endoscopic Retrograde
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
Exercise
×
Clear all
NCT02162914
2020-07-31
REACHIN
Erasme University Hospital
Phase 2
Unknown
66 enrolled